DK2053408T3 - Fremgangsmåde til strukturel karakterisering af et rekombinant polyklonalt protein eller en polyklonal cellelinje - Google Patents

Fremgangsmåde til strukturel karakterisering af et rekombinant polyklonalt protein eller en polyklonal cellelinje

Info

Publication number
DK2053408T3
DK2053408T3 DK09151073.5T DK09151073T DK2053408T3 DK 2053408 T3 DK2053408 T3 DK 2053408T3 DK 09151073 T DK09151073 T DK 09151073T DK 2053408 T3 DK2053408 T3 DK 2053408T3
Authority
DK
Denmark
Prior art keywords
polyclonal
cell line
structural characterization
recombinant
protein
Prior art date
Application number
DK09151073.5T
Other languages
English (en)
Inventor
Lone Rasmussen
Torben Frandsen
Soren Rasmussen
Peter Andersen
Original Assignee
Symphogen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphogen As filed Critical Symphogen As
Application granted granted Critical
Publication of DK2053408T3 publication Critical patent/DK2053408T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Document Processing Apparatus (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK09151073.5T 2004-07-20 2005-07-20 Fremgangsmåde til strukturel karakterisering af et rekombinant polyklonalt protein eller en polyklonal cellelinje DK2053408T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200401133 2004-07-20
DKPA200401991 2004-12-22
EP05760790A EP1787126B1 (en) 2004-07-20 2005-07-20 A procedure for characterization of a polyclonal cell line

Publications (1)

Publication Number Publication Date
DK2053408T3 true DK2053408T3 (da) 2012-06-04

Family

ID=35427551

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05760790T DK1787126T3 (da) 2004-07-20 2005-07-20 Fremgangsmåde til karakterisering af en polyklonal cellelinie
DK09151073.5T DK2053408T3 (da) 2004-07-20 2005-07-20 Fremgangsmåde til strukturel karakterisering af et rekombinant polyklonalt protein eller en polyklonal cellelinje

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK05760790T DK1787126T3 (da) 2004-07-20 2005-07-20 Fremgangsmåde til karakterisering af en polyklonal cellelinie

Country Status (19)

Country Link
US (2) US8288109B2 (da)
EP (2) EP1787126B1 (da)
JP (1) JP4870667B2 (da)
KR (1) KR101319848B1 (da)
AT (2) ATE443870T1 (da)
AU (1) AU2005263334C1 (da)
BR (1) BRPI0513714A (da)
CA (1) CA2574146C (da)
DE (1) DE602005016818D1 (da)
DK (2) DK1787126T3 (da)
ES (2) ES2381531T3 (da)
HK (2) HK1101043A1 (da)
IL (2) IL180169A (da)
MX (1) MX2007000551A (da)
NO (1) NO20070931L (da)
NZ (1) NZ552264A (da)
PL (2) PL1787126T3 (da)
RU (1) RU2426795C2 (da)
WO (1) WO2006007853A2 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1583830T1 (sl) 2003-01-07 2006-12-31 Symphogen As Postopek za pripravo rekombinantnih poliklonskih proteinov
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
EA014182B1 (ru) 2004-07-20 2010-10-29 Симфоген А/С КОМПОЗИЦИЯ ПОЛИКЛОНАЛЬНЫХ АНТИ-RhD АНТИТЕЛ, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ КОМПОЗИЦИИ
PL1787126T3 (pl) 2004-07-20 2010-03-31 Symphogen As Sposób charakteryzowania poliklonalnej linii komórkowej
AU2006322445B2 (en) 2005-12-05 2011-05-12 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
WO2008104183A2 (en) * 2007-03-01 2008-09-04 Symphogen A/S Recombinant anti-epidermal growth factor receptor antibody compositions
EP2121920B1 (en) 2007-03-01 2011-08-24 Symphogen A/S Method for cloning cognate antibodies
JP2010534057A (ja) 2007-03-06 2010-11-04 シムフォゲン・アクティーゼルスカブ 呼吸器合胞体ウイルス感染症を治療するための組換え抗体
CA2680792A1 (en) * 2007-03-15 2008-09-18 Biogen Idec Ma Inc. Treatment of autoimmune disorders
SI2152872T1 (sl) 2007-05-25 2011-01-31 Symphogen As Postopek za pripravo rekombinantnega poliklonskega proteina
JP2008289483A (ja) * 2007-05-25 2008-12-04 Symphogen As 真核生物系において発現可能な形質転換体のスクリーニング
MX2010002044A (es) * 2007-09-07 2010-03-18 Symphogen As Metodos para produccion recombinante de anticuerpos anti-virus sincitial respiratorio (anti-rsv).
MX2010005377A (es) * 2007-11-22 2010-06-25 Symphogen As Metodo para caracterizacion de proteina policlonal recombinante.
CN102007146A (zh) * 2008-04-23 2011-04-06 西福根有限公司 用于制备多克隆蛋白质的方法
BRPI0917352A2 (pt) * 2008-08-29 2017-08-22 Symphogen As Métodos para produção de uma biblioteca de pares cognatos que compreende sequências ligadas que codificam regiões variáveis e para gerar um vetor que codifica um anticorpo quimérico com regiões de seres humanos constantes e regiões variáveis não humanas, biblioteca de vetores, e método para produção de uma biblioteca de sequências de imunoglobulina derivadas de aves
AU2009287163B2 (en) 2008-08-29 2014-11-13 Les Laboratoires Servier Recombinant anti-Epidermal Growth Factor Receptor antibody compositions
US8821879B2 (en) 2009-09-04 2014-09-02 Xoma Technology Ltd. Anti-botulism antibody coformulations
US20120264155A1 (en) * 2009-10-09 2012-10-18 Symphogen A/S Multiplex Quantitation of Individual Recombinant Proteins in a Mixture by Signature Peptides and Mass Spectrometry
MX360403B (es) * 2010-04-15 2018-10-31 Abbvie Inc Proteinas de union a amiloide beta.
JP6186277B2 (ja) 2010-11-01 2017-08-23 シムフォゲン・アクティーゼルスカブＳｙｍｐｈｏｇｅｎ Ａ／Ｓ 抗ｈｅｒ３抗体および組成物
EP2953970A4 (en) 2013-02-08 2016-06-29 Misfolding Diagnostics Inc TRANSTYRETIN ANTIBODIES AND USES THEREOF
UY35517A (es) 2013-04-04 2014-10-31 Mabxience S A Un procedimiento para aumentar la formación de ácido piroglutamico de una proteína
WO2015093925A1 (es) * 2013-12-19 2015-06-25 CASTRO ALDRETE, Jorge Isaac Método de producción de anticuerpos específicos
TW201623331A (zh) * 2014-03-12 2016-07-01 普羅帝納生物科學公司 抗黑色素瘤細胞黏著分子（ｍｃａｍ）抗體類及使用彼等之相關方法
US11680948B2 (en) 2016-08-12 2023-06-20 Abreos Biosciences, Inc. Detection and quantification of natalizumab
WO2019243626A1 (en) * 2018-06-22 2019-12-26 Genmab A/S Method for producing a controlled mixture of two or more different antibodies
CN112816595A (zh) * 2021-01-06 2021-05-18 海默斯（重庆）医学生物技术有限公司 一种重组角蛋白液体制剂及其纯度检测方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0162918A1 (en) 1983-11-28 1985-12-04 The Board Of Trustees Of The Leland Stanford Junior University HUMAN MONOCLONAL ANTIBODY AGAINST Rh(D) ANTIGEN AND ITS USES
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
US5126130A (en) 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
GB8722018D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722020D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722019D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
AU634186B2 (en) 1988-11-11 1993-02-18 Medical Research Council Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
GB8906129D0 (en) 1989-03-17 1989-05-04 Central Blood Lab Authority Pharmaceutical preparations
GB8919761D0 (en) 1989-09-01 1989-10-18 Central Blood Lab Authority Chemical compounds
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
US5837268A (en) * 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
DE69328135D1 (de) 1992-06-26 2000-04-27 Aetsrn Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
ATE243745T1 (de) 1994-01-31 2003-07-15 Univ Boston Bibliotheken aus polyklonalen antikörpern
FR2724182B1 (fr) 1994-09-02 1996-12-13 Pasteur Institut Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
US6111166A (en) 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
JP3841360B2 (ja) 1996-06-24 2006-11-01 ツェットエルベー・ベリング・アクチェンゲゼルシャフト リーサスｄ抗原に対して特異性を有する抗原結合性構造を形成し得るポリペプチド、それらをコードするｄｎａ及びその調製方法並びに使用
US5876925A (en) 1996-10-11 1999-03-02 The Trustees Of The University Of Pennsylvania Magnetically activated cell sorting for production of proteins
US6255455B1 (en) 1996-10-11 2001-07-03 The Trustees Of The University Of Pennsylvania Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
RO120148B1 (ro) 1997-03-14 2005-09-30 Idec Pharmaceuticals Corporation Sistem vector şi procedeu de inserţie a unui fragment adn, în genomul celulelor de mamifere
JPH11174038A (ja) * 1997-12-10 1999-07-02 Tosoh Corp 蛋白質の分離精製法
WO2000011155A1 (en) 1998-08-19 2000-03-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for genomic modification
US20020155114A1 (en) * 1998-08-31 2002-10-24 James D. Marks Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
US6395538B1 (en) * 1999-07-16 2002-05-28 Human Genome Sciences, Inc. Method and system for providing real-time, in situ biomanufacturing process monitoring and control in response to IR spectroscopy
ATE463569T1 (de) 1999-07-23 2010-04-15 Univ California Dna-rekombination in eukaryotischen zellen mittels des rekombinationszentrums vom bakteriophag phic31
EP1106625A1 (en) 1999-11-17 2001-06-13 ZLB Bioplasma AG Rhesus D specific peptide sequences
WO2001058925A2 (en) 2000-02-08 2001-08-16 The Regents Of The University Of Michigan Protein separation and display
JP2003534533A (ja) 2000-02-08 2003-11-18 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン タンパク質のディファレンシャルディスプレイのマッピング
EP1385869A2 (en) 2000-02-08 2004-02-04 The Regents Of The University Of Michigan Protein mapping
CA2410586C (en) 2000-05-26 2010-07-20 Symphogen A/S Recombinant or purified polyclonal antibodies for treating allergy
US6610472B1 (en) 2000-10-31 2003-08-26 Genetastix Corporation Assembly and screening of highly complex and fully human antibody repertoire in yeast
JP2004514444A (ja) * 2000-11-28 2004-05-20 アプライド　モレキュラー　エボリューション，　インコーポレイテッド 二重ｌｏｘ組換えに基づく真核生物発現ライブラリーおよび使用方法
CA2433281C (en) 2000-12-26 2011-02-22 The Institute For Systems Biology Rapid and quantitative proteome analysis and related methods
AU2002367582A1 (en) * 2001-07-17 2003-09-29 Ciphergen Biosystems, Inc. Latex based adsorbent chip
DE60211744T3 (de) * 2001-12-08 2010-07-01 Micromass Uk Ltd. Massenspektrometrie-verfahren
US20040033591A1 (en) 2002-05-31 2004-02-19 The Regents Of The University Of Michigan Automated protein analysis system
JP4836451B2 (ja) 2002-07-18 2011-12-14 メルス ベー ヴェー 抗体混合物の組換え生産
JP2004101477A (ja) * 2002-09-12 2004-04-02 Yoshio Yamauchi ２次元高速液体クロマトグラフ装置及びそれを用いた蛋白質分析装置
AU2003284227A1 (en) 2002-10-15 2004-05-04 The Regents Of The University Of Michigan Multidimensional protein separation system
SI1583830T1 (sl) 2003-01-07 2006-12-31 Symphogen As Postopek za pripravo rekombinantnih poliklonskih proteinov
US20060275766A1 (en) * 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
PL1787126T3 (pl) 2004-07-20 2010-03-31 Symphogen As Sposób charakteryzowania poliklonalnej linii komórkowej
EA014182B1 (ru) 2004-07-20 2010-10-29 Симфоген А/С КОМПОЗИЦИЯ ПОЛИКЛОНАЛЬНЫХ АНТИ-RhD АНТИТЕЛ, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ КОМПОЗИЦИИ
AU2006322445B2 (en) 2005-12-05 2011-05-12 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
US20100040606A1 (en) 2006-03-06 2010-02-18 Symphogen A/S Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
MX2010005377A (es) 2007-11-22 2010-06-25 Symphogen As Metodo para caracterizacion de proteina policlonal recombinante.

Also Published As

Publication number Publication date
NO20070931L (no) 2007-04-17
US20130203063A1 (en) 2013-08-08
IL203017A (en) 2013-08-29
JP4870667B2 (ja) 2012-02-08
KR101319848B1 (ko) 2013-10-18
RU2007106050A (ru) 2008-08-27
US9029091B2 (en) 2015-05-12
IL180169A (en) 2011-04-28
DK1787126T3 (da) 2009-12-21
HK1101043A1 (en) 2007-10-05
AU2005263334A1 (en) 2006-01-26
BRPI0513714A (pt) 2008-05-13
DE602005016818D1 (de) 2009-11-05
AU2005263334B2 (en) 2010-08-05
IL180169A0 (en) 2007-06-03
JP2008506960A (ja) 2008-03-06
ATE443870T1 (de) 2009-10-15
WO2006007853A2 (en) 2006-01-26
ATE548657T1 (de) 2012-03-15
RU2426795C2 (ru) 2011-08-20
ES2332524T3 (es) 2010-02-08
NZ552264A (en) 2010-03-26
EP2053408A2 (en) 2009-04-29
EP1787126B1 (en) 2009-09-23
EP1787126A2 (en) 2007-05-23
AU2005263334C1 (en) 2011-01-20
CA2574146C (en) 2015-06-30
US20080131882A1 (en) 2008-06-05
CA2574146A1 (en) 2006-01-26
EP2053408B1 (en) 2012-03-07
US8288109B2 (en) 2012-10-16
PL1787126T3 (pl) 2010-03-31
ES2381531T3 (es) 2012-05-29
MX2007000551A (es) 2007-03-30
WO2006007853A3 (en) 2006-05-18
KR20070032078A (ko) 2007-03-20
HK1133076A1 (en) 2010-03-12
EP2053408A3 (en) 2009-07-29
PL2053408T3 (pl) 2012-08-31

Similar Documents

Publication Publication Date Title
DK2053408T3 (da) Fremgangsmåde til strukturel karakterisering af et rekombinant polyklonalt protein eller en polyklonal cellelinje
BRPI0507433C1 (pt) anticorpo monoclonal recombinante ou sua parte de ligação ao antígeno, composição, ácido nucleico isolado, vetor de expressão, e, kit
MX2010005377A (es) Metodo para caracterizacion de proteina policlonal recombinante.
Sander et al. A new method to bind allergens for the measurement of specific IgE antibodies
WO2009036209A3 (en) Homogeneous antibody populations
ATE554390T1 (de) Verfahren zur gewinnung von antikörpern
EA201590631A1 (ru) Антигенсвязывающие белки, способные связывать тимусный стромальный лимфопоэтин
BRPI0716438A8 (pt) Proteínas ligantes interleucina-1,3
ATE447180T1 (de) Verfahren zur vorbehandlung von proben sowie immuntestverfahren unter dessen verwendung
ATE428771T1 (de) Antikörper gegen hundepankreaslipase
BRPI0820885B8 (pt) "anticorpo ou fraguimento do mesmo, célula de hibridoma, polinucleotídeo, polipeptídeo compreendendoum domínio de cadeia pesada ou leve de anticorpo, método para detecção de gravidez em um animal bovino, kit e método de purificação de um antígeno principal associado à gravidez (pag)".
WO2009132132A3 (en) Prediction of an individual's risk of developing rheumatoid arthritis
ATE538217T1 (de) Erkennung von ektopischen schwangerschaften
WO2006070371A3 (en) Method for obtaining modified proteins and viruses with intact native binding site
DE602005022757D1 (de) Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen
DK0863153T3 (da) Skumproteiner, monoklonale anatistoffer derimid og deres anvendelse
SE0003566D0 (sv) A method for the quantitative determination of one or more compounds
ATE532796T1 (de) Immunassays zur spezifischen bestimmung von scca- isoformen
Mehand et al. Estimation of analyte concentration by surface plasmon resonance-based biosensing using parameter identification techniques
Altinier et al. An IgE multiple myeloma: contradictory findings in clinical laboratory testing
ATE423133T1 (de) Verfahren und materialien zur behandlung von entzündungen unter verwendung eines polypeptides das einen eigenen-c5 aminosaüresegment und einen nicht-eigenen aminosaüresegment enthält
WO2004084841A3 (en) Novel anti-feline albumin antibodies and methods of detecting early renal disease
Bentley The crystal structures of complexes formed between lysozyme and antibody fragments.
WO2005058362A3 (en) Method for opening tight junctions comprising the use of jam-1, claudin-4 and occludin protein antagonists as well as sirna molecules
Kelner et al. Analytical strategy for biopharmaceutical development